Cargando…

Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea

The aim of the study was to investigate the genetic and immunogenic features of commercial vaccines against infectious bronchitis virus (IBV), which is a major contagious pathogen of poultry. Although numerous vaccines have been developed based on the genetic characteristics of field strains, the co...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Ji Seung, Lee, Rangyeon, Yoon, Sung-il, Lee, Geun-Shik, Sung, Haan Woo, Kwon, Hyuk Moo, Park, Jeongho
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272870/
https://www.ncbi.nlm.nih.gov/pubmed/35816229
http://dx.doi.org/10.1007/s00705-022-05519-2
_version_ 1784744961503133696
author Jung, Ji Seung
Lee, Rangyeon
Yoon, Sung-il
Lee, Geun-Shik
Sung, Haan Woo
Kwon, Hyuk Moo
Park, Jeongho
author_facet Jung, Ji Seung
Lee, Rangyeon
Yoon, Sung-il
Lee, Geun-Shik
Sung, Haan Woo
Kwon, Hyuk Moo
Park, Jeongho
author_sort Jung, Ji Seung
collection PubMed
description The aim of the study was to investigate the genetic and immunogenic features of commercial vaccines against infectious bronchitis virus (IBV), which is a major contagious pathogen of poultry. Although numerous vaccines have been developed based on the genetic characteristics of field strains, the continual emergence of variants decreases vaccine efficacy and cross-protection. To address this issue, we compared the S1 gene sequences of three IBV vaccines commercially available in Korea with those of various field isolates. Phylogenetic analysis showed that the vaccine strains clustered into two different lineages. Comparison of commercial vaccines with their parental viruses showed that most of the genetic variability occurred around hypervariable regions (HVRs). Conversely, antigenic stimulation with commercial vaccines and regional IBV variants was not sufficient to alter major immune cell phenotypes. Our study suggests that vaccines should be selected carefully based on their genetic background because genetic variability can affect the antigenicity of vaccines and host immune responses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00705-022-05519-2.
format Online
Article
Text
id pubmed-9272870
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-92728702022-07-11 Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea Jung, Ji Seung Lee, Rangyeon Yoon, Sung-il Lee, Geun-Shik Sung, Haan Woo Kwon, Hyuk Moo Park, Jeongho Arch Virol Original Article The aim of the study was to investigate the genetic and immunogenic features of commercial vaccines against infectious bronchitis virus (IBV), which is a major contagious pathogen of poultry. Although numerous vaccines have been developed based on the genetic characteristics of field strains, the continual emergence of variants decreases vaccine efficacy and cross-protection. To address this issue, we compared the S1 gene sequences of three IBV vaccines commercially available in Korea with those of various field isolates. Phylogenetic analysis showed that the vaccine strains clustered into two different lineages. Comparison of commercial vaccines with their parental viruses showed that most of the genetic variability occurred around hypervariable regions (HVRs). Conversely, antigenic stimulation with commercial vaccines and regional IBV variants was not sufficient to alter major immune cell phenotypes. Our study suggests that vaccines should be selected carefully based on their genetic background because genetic variability can affect the antigenicity of vaccines and host immune responses. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00705-022-05519-2. Springer Vienna 2022-07-11 2022 /pmc/articles/PMC9272870/ /pubmed/35816229 http://dx.doi.org/10.1007/s00705-022-05519-2 Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature 2022 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Jung, Ji Seung
Lee, Rangyeon
Yoon, Sung-il
Lee, Geun-Shik
Sung, Haan Woo
Kwon, Hyuk Moo
Park, Jeongho
Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea
title Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea
title_full Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea
title_fullStr Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea
title_full_unstemmed Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea
title_short Genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in Korea
title_sort genetic and immunological characterization of commercial infectious bronchitis virus vaccines used in korea
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9272870/
https://www.ncbi.nlm.nih.gov/pubmed/35816229
http://dx.doi.org/10.1007/s00705-022-05519-2
work_keys_str_mv AT jungjiseung geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea
AT leerangyeon geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea
AT yoonsungil geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea
AT leegeunshik geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea
AT sunghaanwoo geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea
AT kwonhyukmoo geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea
AT parkjeongho geneticandimmunologicalcharacterizationofcommercialinfectiousbronchitisvirusvaccinesusedinkorea